Take a look around.
News
Press Releases
June 19, 2019
Bayer's Stivarga® (regorafenib) becomes first compound used in clinical trial platform to investigate new therapies for brain cancer
Bayer announced today that the Stivarga® (regorafenib) arm of the platform trial GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) has opened enrollment for patients with...
Learn moreJune 19, 2019
Bayer Donation of $45,000 Helped Fund Development of Cook Museum of Natural Science
The Environmental Science business of Bayer is honored to have contributed $45,000 toward the development of the new Cook Museum of Natural Science that opened on June 7 in Decatur, AL. The museum...
Learn more
